Jadhav, Vasant https://orcid.org/0000-0002-6666-0250
Vaishnaw, Akshay
Fitzgerald, Kevin
Maier, Martin A. https://orcid.org/0000-0002-4987-0184
Article History
Received: 5 October 2022
Accepted: 15 December 2023
First Online: 26 February 2024
Competing interests
: All authors are or have been employees of Alnylam Pharmaceuticals during the writing of the manuscript and report ownership of equity in Alnylam Pharmaceuticals: V.J. is chief technology officer; A.V. is chief innovation officer; K.F. is chief scientific officer; and M.A.M. is senior vice-president, head of oncology.